The prevalence of cumulative alloimmunization in patients with sickle cell disease at King Fahad University Hospital
BACKGROUND: Sickle cell disease (SCD) is caused by a mutation in the beta-globin gene. Red blood cell (RBC) transfusion is considered the mainstay of management. On the other hand, it carries many side effects, of which alloimmunization is the most significant. AIMS AND OBJECTIVES: The aim of this s...
Main Author: | Rabab Ahmad AlDawood |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2022;volume=13;issue=1;spage=35;epage=40;aulast=AlDawood |
Similar Items
-
Red blood cell alloimmunization in patients with sickle cell disease in Turkey: a single center retrospective cohort study
by: Soner Solmaz, et al.
Published: (2016-12-01) -
Alloimmunization in children with sickle cell disease: A tertiary care experience
by: Sujata Sharma, et al.
Published: (2023-06-01) -
Prevalence of alloimmunization in major beta thalassemia in northern Iran (2010)
by: Kosaryan M, et al.
Published: (2014-07-01) -
Alloimmunization in Transfusion Dependent Thalassaemic Patients.
by: Saad H. Ahmed, et al.
Published: (2010-04-01) -
Trends of Erythrocyte Alloimmunization in Transfused Women
by: Sunia Ghaffar, et al.
Published: (2022-12-01)